Mallinckrodt Files Suit against U.S. Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) to Protect Medicaid Patient Access to Acthar(R) Gel
Company challenges CMS' unexplained and unlawful reversal of its repeated 2012 written authorizations on calculation of Medicaid Rebates for Acthar Gel
After extensive efforts to resolve matter, Mallinckrodt seeks Court intervention to ensure that CMS f... Biopharmaceuticals, Reimbursement, Litigation Mallinckrodt, Acthar Gel
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news